Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03455699 · ClinicalTrials.gov registry record
VeClose Five Year Follow-Up Extension Study
A clinical trial of Great Saphenous Vein (GSV) With Venous Reflux Disease, sponsored by Medtronic Endovascular.
- Completed
- Registry status
- 114
- Enrollment target
- 9
- Study locations
NCT03455699: Completed study of Great Saphenous Vein (GSV) With Venous Reflux Disease, sponsored by Medtronic Endovascular.
NCT03455699 is a study of Great Saphenous Vein (GSV) With Venous Reflux Disease that has completed, run by Medtronic Endovascular. The registered enrollment target is 114 participants. The trial reports 9 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03455699, a study of Great Saphenous Vein (GSV) With Venous Reflux Disease, has completed, sponsored by Medtronic Endovascular.
- COMPLETED
- Registry status
- 114 participants
- Enrollment target
- 9
- Study locations
Study Summary
The VeClose Five Year Follow-up Extension Study will seek to gain additional follow-up data from the patients enrolled in the VeClose study (NCT01807585).
Primary Outcome
Complete closure is defined as Doppler ultrasound examination showing closure along entire treated target vein segment with no discrete segments of patency exceeding 5cm.
Conditions Studied
Interventions
- DEVICE VenaSeal SCS
- DEVICE ClosureFast Radiofrequency Ablation (RFA)
- DEVICE Roll-In (VenaSeal SCS)
Study Locations (9)
Arizona
- Morrison Vein Institute - Scottsdale
California
- GBK Cosmetic Laser Dermatology - San Diego
Colorado
- Radiology Imaging Associates (RIA) - Greenwood Village
Illinois
- Prairie Education & Research Cooperative - Springfield
Maryland
- MD Laser Skin & Vein Institute - Hunt Valley
New York
- Vein Institute of Buffalo - North Tonawanda
Oregon
- Inovia Vein Speciality Center - Bend
Virginia
- Sentara Vascular Specialists - Virginia Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2016-07 |
| Est. Completion | 2019-01 |
What the finished NCT03455699 record still lists
NCT03455699 is an observational study that tracks outcomes without assigning an intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Great Saphenous Vein (GSV) With Venous Reflux Disease appearing as the primary indexed condition, and to 3 interventions - of which VenaSeal SCS is the first listed.
NCT03455699 lists 9 locations in 9 states (Arizona, California, Colorado).
Frequently Asked Questions
What is clinical trial NCT03455699 about?
NCT03455699 is a clinical study titled "VeClose Five Year Follow-Up Extension Study". The VeClose Five Year Follow-up Extension Study will seek to gain additional follow-up data from the patients enrolled in the VeClose study (NCT01807585).
What is the current status of trial NCT03455699?
This trial is currently completed. The enrollment target is 114 participants. The study started on 2016-07. Estimated completion is 2019-01.
What conditions does trial NCT03455699 study?
This clinical trial studies the following conditions: Great Saphenous Vein (GSV) With Venous Reflux Disease.
What interventions are being tested in trial NCT03455699?
The interventions under investigation include: VenaSeal SCS (DEVICE), ClosureFast Radiofrequency Ablation (RFA) (DEVICE), Roll-In (VenaSeal SCS) (DEVICE).
Who is sponsoring clinical trial NCT03455699?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03455699 being conducted?
This trial has 9 study locations across Arizona, California, Colorado, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Great Saphenous Vein (GSV) With Venous Reflux Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia